ID   LMBL2_RAT               Reviewed;         703 AA.
AC   Q3MIF2;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 1.
DT   24-JUL-2024, entry version 107.
DE   RecName: Full=Lethal(3)malignant brain tumor-like protein 2;
DE            Short=L(3)mbt-like protein 2;
GN   Name=L3mbtl2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-681; SER-685 AND SER-687, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain
CC       the transcriptionally repressive state of genes, probably via a
CC       modification of chromatin, rendering it heritably changed in its
CC       expressibility. Its association with a chromatin-remodeling complex
CC       suggests that it may contribute to prevent expression of genes that
CC       trigger the cell into mitosis. Binds to monomethylated and dimethylated
CC       'Lys-20' on histone H4. Binds histone H3 peptides that are
CC       monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27' (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Part of the E2F6.com-1 complex in G0 phase composed of E2F6,
CC       MGA, MAX, TFDP1, CBX3, BAT8, EUHMTASE1, RING1, RNF2, MBLR, BAT8 and
CC       YAF2. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC101865; AAI01866.1; -; mRNA.
DR   RefSeq; NP_001028867.1; NM_001033695.1.
DR   AlphaFoldDB; Q3MIF2; -.
DR   SMR; Q3MIF2; -.
DR   STRING; 10116.ENSRNOP00000031908; -.
DR   iPTMnet; Q3MIF2; -.
DR   PhosphoSitePlus; Q3MIF2; -.
DR   PaxDb; 10116-ENSRNOP00000031908; -.
DR   Ensembl; ENSRNOT00000034998.7; ENSRNOP00000031908.5; ENSRNOG00000024743.7.
DR   Ensembl; ENSRNOT00055048578; ENSRNOP00055039935; ENSRNOG00055028069.
DR   Ensembl; ENSRNOT00060051145; ENSRNOP00060042554; ENSRNOG00060029467.
DR   Ensembl; ENSRNOT00065054804; ENSRNOP00065045070; ENSRNOG00065031816.
DR   GeneID; 300320; -.
DR   KEGG; rno:300320; -.
DR   UCSC; RGD:1308569; rat.
DR   AGR; RGD:1308569; -.
DR   CTD; 83746; -.
DR   RGD; 1308569; L3mbtl2.
DR   eggNOG; KOG3766; Eukaryota.
DR   GeneTree; ENSGT00940000153840; -.
DR   HOGENOM; CLU_005352_2_1_1; -.
DR   InParanoid; Q3MIF2; -.
DR   OMA; QVNYPGP; -.
DR   OrthoDB; 5405166at2759; -.
DR   PhylomeDB; Q3MIF2; -.
DR   Reactome; R-RNO-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-RNO-8953750; Transcriptional Regulation by E2F6.
DR   PRO; PR:Q3MIF2; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000024743; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0042393; F:histone binding; ISO:RGD.
DR   GO; GO:0035064; F:methylated histone binding; ISS:UniProtKB.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; ISO:RGD.
DR   GO; GO:0007398; P:ectoderm development; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IBA:GO_Central.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0048863; P:stem cell differentiation; ISO:RGD.
DR   GO; GO:0072089; P:stem cell proliferation; ISO:RGD.
DR   CDD; cd20100; MBT_dSfmbt-like_rpt4; 1.
DR   CDD; cd20121; MBT_L3MBTL2_rpt1; 1.
DR   CDD; cd20124; MBT_L3MBTL2_rpt2; 1.
DR   CDD; cd20127; MBT_L3MBTL2_rpt3; 1.
DR   Gene3D; 2.30.30.140; -; 4.
DR   Gene3D; 3.30.60.160; -; 1.
DR   InterPro; IPR004092; Mbt.
DR   InterPro; IPR047356; MBT_L3MBTL2_rpt1.
DR   InterPro; IPR047357; MBT_L3MBTL2_rpt2.
DR   InterPro; IPR050548; PcG_chromatin_remod_factors.
DR   InterPro; IPR012313; Znf_FCS.
DR   InterPro; IPR038603; Znf_FCS_sf.
DR   PANTHER; PTHR12247:SF64; LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 2; 1.
DR   PANTHER; PTHR12247; POLYCOMB GROUP PROTEIN; 1.
DR   Pfam; PF02820; MBT; 4.
DR   Pfam; PF21319; zf-FCS_1; 1.
DR   SMART; SM00561; MBT; 4.
DR   SUPFAM; SSF63748; Tudor/PWWP/MBT; 4.
DR   PROSITE; PS51079; MBT; 4.
DR   PROSITE; PS51024; ZF_FCS; 1.
PE   1: Evidence at protein level;
KW   Chromatin regulator; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..703
FT                   /note="Lethal(3)malignant brain tumor-like protein 2"
FT                   /id="PRO_0000346785"
FT   REPEAT          179..283
FT                   /note="MBT 1"
FT   REPEAT          291..391
FT                   /note="MBT 2"
FT   REPEAT          397..500
FT                   /note="MBT 3"
FT   REPEAT          508..604
FT                   /note="MBT 4"
FT   ZN_FING         81..116
FT                   /note="FCS-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00367"
FT   REGION          1..70
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          604..649
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          672..703
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        32..49
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        617..637
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         90
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00367"
FT   BINDING         93
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00367"
FT   BINDING         110
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00367"
FT   BINDING         114
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00367"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
FT   MOD_RES         338
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
FT   MOD_RES         681
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         685
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        405
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
FT   CROSSLNK        647
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
FT   CROSSLNK        673
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
FT   CROSSLNK        698
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
FT   CROSSLNK        698
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q969R5"
SQ   SEQUENCE   703 AA;  78967 MW;  6FFFE8B8B4BD88E9 CRC64;
     MEKPRGTEET PSSEPMEEEE DDDLELFGGY DSFRSYNSSA GSESSSYLEE SSEAENEDRE
     AGELPTSPLH LFSSANNRAL DGSGSEPAVC EMCGIVGTRE AFFSKTKRFC SVSCSRSYSS
     NSKKASILAR LQGKPPTKKA KVLHKAAWSA KIGAFLHAQG TGQLADGTPT GQDALVLGFD
     WGKFLKDHSY KAAPVGCFKH VPLYDQWEDV MKGMKVEVLN SDAVLPSRVY WIATVIQAAG
     YRVLLRYEGF ENDASHDFWC NLGTVDVHPI GWCAINSKIL VPPRTIHAKF TDWKSYLMKR
     LVGSRTLPAD FHIKMVESMK YPFRQGMRLE VVDKTQVSRT RMAVVDTVIG GRLRLLYEDG
     DSDDDFWCHM WSPLIHPVGW SRRVGHGIKM SERRCDMSHH PTFRKIYCDA VPYLFKKVRA
     VYTEGGWFEE GMKLEAIDPL NLGNICVATI CKVLLDGYLM ICVDGGPSTD GSDWFCYHAS
     SHAIFPATFC QKNDIELTPP KGYETQPFDW ESYLEKTKSK AAPARLFNMD CPNHGFKVGM
     KLEAVDLMEP RLICVATVKR VVHRLLSIHF DGWDNEYDQW VDCESPDIYP VGWCELTGYQ
     LQPPVSAEPN TPQKGKDATK KKKKQFGKKR KRIPSAKTRP LRQSSKKPLL EDNLEALGVS
     EPVPDDIIAV CVKEEHQDLP SPDRSPSPLL PLPTESIKQE RDS
//
